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Executive Summary
Acute Ischemic Stroke accounts for 70% of all strokes globally with greater than 80% in
the United States alone (Phipps & Cronin, 2020). The prevalence of stroke has increased the
need for education, awareness, and improvements in assessment skills. Post-stoke depression
(PSD) is a common complication of stroke and the inclusion of a depression screening tool for
every stroke patient can improve overall outcomes. One-third of all stroke patients experience
depression and it is associated with a deficiency in functional outcomes (Towfighi et al., 2017).
A stroke depression screening tool is used to assess stroke patients and their feelings, focusing on
questions that identify major depressive symptoms. The goal of this tool is to identify and treat
patients as soon as possible, to increase functional outcomes and decrease the likelihood of
hospital readmission related to worsening deficits. The Patient Health Questionnaire-9 (PHQ-9)
is a high sensitivity screening tool recognized for its ability to assess for post-stroke depression
(Dajapratham et al., 2020). Research has shown that this nine-question questionnaire uses the
major depressive disorder criteria for diagnosis (Dajapratham et al., 2020). Although depression
can manifest itself at any point during a patients’ progress early detection is suggested for
prompt treatment and to prevent poor functional outcomes (Karamchandani et al., 2015).
At Ochsner LSU Health Shreveport (OLSH), the only mental health screening currently
used is a suicide risk screening that is asked during triage in the emergency department or during
a direct floor admission. Treatment that follows a depression screening can change the trajectory
of stroke care and improve the patients’ rehabilitation participation. An appropriate depression
screening tool could introduce the patient to early interventions for PSD. Depression influences
rehabilitation potential and functional recovery (Harris et al., 2017). As the diagnosis of stroke
continues to rise, there may also be a rise in depression.
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The goal of this benchmark project is to assess, identify and treat the depressive
symptoms of patients with deficits following a stroke The PHQ-9 questionnaire tool for
assessment will be integrated into electronic health record. Once the tool is approved by the Epic
inpatient documentation council it will be available to inpatient nursing staff to use for every
patient with an admission diagnosis of stroke. Education will be a critical piece of the
questionnaire implementation and an ongoing process. Ochsner LSU Health Shreveport’s stroke
team continues to report increases in stroke patient volume, this increase ignites the need to
introduce and implement this project quickly and efficiently.
Rationale for the Project
Physical deficits following stroke tend to be the focus of treatment; although physical
deficits are important, it is also important to acknowledge the psychological comorbidities
that can be associated with this disease process (Vermeer et al., 2018). Experiencing a stroke
is devastating to patients and their caregivers. It is the responsibility of the nurses and
physicians to be proactive when it comes to awareness and assessment of significant mood
changes. These mood changes may affect a patient’s ability to perform activities of daily
living (ADLs). Post-stroke depression implications have been overlooked, ignored, and
underestimated (Dar et al., 2017).
Patients that experience mental health concerns post-stroke need to be assessed early in
order to be provided with appropriate treatment (Meng et al., 2017). The process of
assessment is solely based on the diagnosis of acute ischemic stroke on hospital admission.
Each patient needs access to the same assessment screening tool for continuity of care. The
PHQ-9 and EHR integration is key to the successful execution of the screening tool
(McIntosh, 2017). Patients at a certified stroke facility should have confidence that every
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possible avenue has been pursued to evaluate their symptoms. During unit admission
screenings identify the need for intervention sooner within the patient care process. This
PHQ-9 questionnaire is to detect depression in patients who otherwise may not be identified
until much later in their hospital stay (Levis et al., 2019). The standard cut for this nine-item
questionnaire is 10 or greater, the cutoff number represents a significant possibility of major
depressive symptoms (Levis et al., 2019).
At Ochsner LSU Health, each patient admitted to the facility will receive a standard
rehabilitation assessment from a physical therapist and an occupational therapist. The
multidisciplinary approach to stroke patient care is beneficial to the patients’ recovery status.
After a patient receives an assessment it will be the nurses’ responsibility to ascertain and
report the depression screening findings to the physical therapist, the admitting physician and
consult the psychiatrist if appropriate. For optimal recovery results, the team members will
properly treat the depression symptoms while admitted as an inpatient before home discharge
or to an inpatient rehabilitation facility. Stroke depression and its effects on rehabilitation is
not widely addressed, this project will bring these much-needed discussions to the forefront
of stroke patient care.
Literature Synthesis
During a review of literature twelve articles were found to have relevance and support of
the benchmark project, 3 cohort studies, 1 retrospective review, 1 quality improvement
review, 1 integrative review, 1 systematic review, 2 cross-sectional studies, 1 descriptive
study, 1 meta-analysis, and 1 case-control study. These articles support the theme of the
project and the benefits this project will have for the patients and the future of stroke care.
The common findings in the research that support the change project are awareness,
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effectiveness, and reliability. The quality improvement project on depression screening noted
that implementation of the depression screening protocol increased the nurses’ general
awareness and objective observation (McIntosh, 2017). Nurses are at the forefront of care
and are typically first to notice PSD, therefore it is critical that early identification and
intervention, through the utilization of the screening tool at unit admission it initiated
(Babkair, 2017; McIntosh, 2017). PSD is a regular occurrence in patients diagnosed with
acute ischemic stroke; a common mental health disease, depression is frequently associated
with impairments to functional outcome (Babkair, 2017; Dar et al., 2017; McIntosh, 2017).
Although depression is a frequent occurrence after stroke, the research has shown that there
is a need for patient-appropriate assessment screening tools. Karamchandani et al. (2015),
McIntosh (2017), and Selvaraj et al. (2021) found that in hospitalized patients there was a
strong correlation between evidence-based screening and functional improvements from
early detection. Providing staff with an easy-to-understand and easy-to-use screening offers
more staff cooperation.
Several studies found that the use of the PHQ-9 as the screening tool detected a
consistent higher “sensitivity of 88% and 88% specificity prediction” for major depression
(Dajapratham et al., 2020; McIntosh,2017; Towfighi et al., 2017). The PHQ-9 has a strong
predictive value for distinguishing between patients with and without major depressive
symptoms (Vermeer et al., 2017). Although the PHQ-9 is not used for diagnosis it assists in
further assessing patients for possible treatments of depressive disorders. Screenings with a
cut-off score of 5 yielded minimal depression; inconsistencies in cut-off scores demonstrated
a larger variability in depression (McIntosh, 2017; Vermeer et al., 2017). PSD and functional
outcome yielded mixed results relating to the overall effects depression has on rehabilitation
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versus results that conclude a significant relevance between depression and rehabilitation
performance (Babkir, 2017; Sharma et al, 2021; Zhao et al., 2018).
Kapoor et al. (2018) found that 30-50% of stroke patients may have limited functional
outcomes due to depression. “Rehabilitation potential and functional outcomes are influenced
by depression” (Harris et al., 2017, p. 2). Torrisi et al. (2018) suggest that unrealistic
rehabilitation expectations affected mood following a stroke and was a dominating factor for
a positive outcome. Psychiatric consults were administered to more than half of the stroke
patients that were found to be experiencing PSD through early screening; rehabilitation is
gear toward the thought that lost cognitive abilities will be recovered and influenced by the
patients’ willingness to rehabilitate (Amaricai & Poenaru, 2016; Ezekiel et al., 2019; Harris
et al., 2017). Treatment for PSD varies facility and physician wide. According to Zhao et al.
(2018), as soon as a patient is diagnosed with PSD the patient should be treated with an
antidepressant based on presenting factors. Overall consensuses suggest the importance of
identifying PSD and the common aspects associated with poor functional outcomes
(Amaricai & Poenaru, 2016; Ezema et al., 2019; Selvaraj et al., 2021; Ezekiel et al., 2019;
Sharma et al., 2021).
Project Stakeholders
Stakeholders for this implementation project are patients, family members, physicians,
mid-level providers, and nurses. The administrative leaders are also key to the approval of the
project. A patients’ overall recovery is dependent on the assessment and follow-through of the
physicians, mid-level providers, and staff nurses. The facility is certified in stroke care;
therefore, the patient should expect optimal evidence-based care that provides them with a
positive outcome on discharge. The patients’ caregivers also have a vital role in depression
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identification and treatment. Ensuring the evidence-based process involves the use of the best
current evidence to assist in making patient care decisions (Melnyk & Fineout-Overholt, 2015).
Patient care is anticipated to be thoughtful, accurate, and professional. Since nurses will be the
driving force behind the depression screening tool implementation their awareness,
identification, and report of the risk factors during early stages is critical to the projects’ success
(Babkir, 2017). Since the tool will be integrated into the EHR and directly affect the nurses, the
screening protocols will be re-evaluated based on nursing input. Nursing input is vital to the
sustainability of the project.
Implementation Plan
New projects are sure to experience challenges along the implementation process, and
acknowledgment of this possibility is imperative to success. Determining possible problems is
the first step to any projects’ successful implementation. Initiating a team of individuals that will
lead the change, encourage the change, and continue to endorse the change is important for the
foundation of the project. It is important to immediately establish an evidence-based change
model with the team, this assists in creating clear guidelines and goals for seamless execution.
Changes in practice should be led by models developed to organize the approaches to change and
the thinking process (Dang et al., 2015). Second, once the stroke unit is fully staffed and open,
nurses will be assigned the PHQ-9 on the hospital’s online learning network (OLN) this learning
tool will be used to teach each nurse how to perform the screening. Upon approval of the PHQ9’s by the EHR implementation team, the questionnaire will be added to EPIC. Once stroke
patients are admitted to the newly opened stroke unit, each patient will be assessed for
depression.
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Ochsner LSU Health Shreveport uses the Plan-Do-Study-Act (PDSA) as an
implementation model. The PDSA is a four-stage cycle using action-oriented learning and the
scientific method (Stevens, 2015). The planning phase demonstrates how the depression
screening tool will benefit the patients. The project’s team will include stroke physicians, staff
nurses, stroke nurses practitioners, the stroke hospital educator, stroke unit nurse managers, and
physical and occupational therapists. This team will have monthly meetings to discuss
accomplishments and areas that may need improvements. The do phase includes a small-scale
implementation of the project; the success of the project will be examined through the reporting
of patients that are positive for depression based on the screening tool along with a matching
psychiatric consultation. The study phase examines the analysis through reports that will
specifically identify the need for changes to the project. This analysis will direct future
corrections and goal adjustments. The recommendations for patients to be treated for depression
will be compared to physical and occupational therapist reports of the patients abilities.
Timetable/Flowchart
The hospital administration is committed to re-opening the stroke unit. Each aspect of the
timeline will be based on the opening. See Flowchart Appendix C
•

The goal is for a Spring 2022 opening of 12 to 14 beds, two of which will be intensive
care beds. These beds will be used for the small-scale implementation.

•

Implementation of depression screening tool into the EHR on unit opening day

•

During the orientation process for the nurses hired for the unit, the education for the
depression screening tool will be introduced. Each nurse will be required to complete the
education within 1 week of hire.
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By week two of re-opening, every patient admitted to the stroke unit should be assessed
for depression screening

•

Week 3, individual reports will be analyzed for missed screening tools, re-education will
occur

•

At the 1-month mark comparison of discharged patients who received rehabilitation and
depression treatment will be assessed. An accurate count of patients will be needed to
understand future requirements

•

Re-evaluation of the stroke patients’ needs and possible adjustments to the plan will be
ongoing.

•

Actual dates pending
Data Collection/Evaluation Plan
❖ Add the PHQ-9 to the electronic health record for use by staff
▪

Generate questionnaire specific report to obtain results of the screening
tool

❖ Obtain psychiatric consult reports for stroke patients discharged to a rehabilitation
facility
❖ Compare rehabilitation progress of patients treated for depression vs. patients who
were positive for depression but refused psychiatric treatment and rehabilitation
▪

The comparison of these two factors will be the tool used to evaluate the
success of the screening implementation.

❖ Incorporate the PDSA to assist with changes that will need to be made to the
project
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Cost/Benefit
Currently, there is no specific cost associated with this project implementation. The staff
education will be required as online training and will not require over time. Online education at
Ochsner LSU Health Shreveport is typically disseminated through an online learning system.
This education course will be a 30-minute module, with 5 questions at the end of the module to
assess understanding of learned skills.
One of the most beneficial aspects of this project will be the goal of reduced readmission
resulting from improved rehabilitation. Readmission related to untreated PSD from a lack of
rehabilitation can cause a major incumbrance to a facility’s available resources. Hospital
readmissions have a significant correlation to depression (Ottenbacher et al., 2012). 30–90-day
hospital readmissions are more prevalent when the patient does not receive rehabilitation therapy
as compared to patients that receive even low-intensity rehabilitation therapy (Andrews et al.,
2015). “Patients with better motor and cognitive abilities at rehabilitation discharge were less
likely to be re-hospitalized, whereas those reporting more depressive symptoms were more likely
to be re-hospitalized” (Ottenbacher et al., 2012, p. 877). Further research regarding the cost
specifically associated with stroke, depression and rehabilitations effects on readmission will be
performed.
Discussion of Results
Caring for stroke patients requires continual assessments and planning. This benchmark
project will aim at identifying depression; a consequence of stroke, which can affect both the
patients’ future activities of daily living as well as the organization’s stroke readmission rates.
PSD awareness may be the catalyst to encourage more facilities to include a depression
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screening tool into the standard of care. Clinical identification through awareness can facilitate
early intervention to enhance rehabilitation recovery (Babkair, 2017). Patients can benefit from
facilities incorporating a PHQ-9 questionnaire into current stroke measures and guidelines. The
standardization of depression treatment can improve rehabilitation abilities and efforts, therefore
improving overall function outcomes.
Conclusion/Recommendations
The ultimate goal is to routinely assess hospitalized stroke patients for depression
(Karamchandani et al., 2015). The community strives to promote stroke prevention by
understanding risk factors through access to education. Education is imperative for patients that
have experienced an acute ischemic infarct. As a result of stroke, PSD is a condition that has not
been widely discussed within the healthcare field. Acknowledgment of how common depression
affects stroke recovery is key to improvements in functional outcomes. The administration’s
awareness and possible financial benefits for the facility can close the gap to the uninformed.
Quality of life may be improved with the recurrent re-evaluation of evidence-based depression
screening protocols. This implementation will produce data that can support depression and other
mental health screenings for multiple disease processes in the future. There needs to be a
continuous evaluation of the evidence-based depression and treatment screening tool for
improvements of how screenings may assist to increase rehabilitation participation willingness.
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Appendix A
Evaluation Table Template
PICOT Question: In patients with physical deficits following acute ischemic stroke (P) how does the use of a post-stroke
depression (PSD) screening protocol at admission (I) compared to no protocol I affect PSD treatment and rehabilitation willingness
(O) before discharge (T)?
PICOT Question Type (Circle): Intervention Etiology

Diagnosis or Diagnostic Test

Prognosis/Prediction Meaning

Caveats
1) The only studies you should put in these tables are the ones that you know answer your question after you have done the
modified rapid critical appraisal (i.e., the keeper studies).
2) Include APA reference
3) Use abbreviations & create a legend for readers & yourself
4) Keep your descriptions brief – there should be NO complete sentences
5) This evaluation is for the purpose of knowing your studies to synthesize.
Place your APA References here (Use correct APA reference format including the hanging indentation):
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Strength of the Evidence (i.e., level of evidence
+ quality [study strengths and weaknesses])
• Strengths and limitations of the study
(Consider the validity of the study and/or
flaws In the method not just what Is stated as
limitations)
• Risk of harm if study intervention or
findings implemented
• Feasibility of use in your practice
• Remember: level of evidence (See Melnyk
& Fineout-Overholt handout) + quality of
evidence = strength of evidence & confidence
to act
• Use the USPSTF grading schema
http://www.ahrq.gov/clinic/3rduspstf/ratings.h
tm

Strengths:
Limitations:
Risk of harm:
Feasibility:
Level of evidence for the PICOT
question type:
Quality of the evidence
USPSTF: Grade:
Certainty:
Article #1
Karamchand
ani et al.
(2015).
Early
depression
screening is

none

Quantitative
Cohort
predictive

Pt admitted • IV= diagnosis
with stroke
of IS
dx n=303
DV=
Total
diagnosis of
eligible n=
ICH stroke
211
IS= 148

Depression
screening
questionnaire
MPHQ-9,
NIHSS, mRS,

Descriptiv
e
statistics,
univariabl
e and
multivaria
ble

Younger age (OR
0.97,95% CI 0.96-0.99)

1.
2.

Female sex (OR 2.06,
95% CI 1.06-4.01)
3.
4.

Level of

Strength: modified screening
instrument provided sooner results
Limitations: prior depression and
antidepressant use of pt. not assessed
prior to study.
Risk of harm: none
Feasibility: very feasible
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ICH n= 63,
pt. comorbidities
, stroke
characterist
ics. No
attrition
rate

feasible in
hospitalized
stroke
patients

Article #2
Vermeer et
al. (2018).
Depressive
symptoms in
individuals
after stroke
in homebased
rehabilitatio
n setting.

None

Article #3
McIntosh,
C. (2017). A
depression
screening
tool protocol
for patients
with acute
stroke: A
quality
improvemen
t project

none

Retrospectiv
e review
using
correlational
regression
Quantitative

A quality
Improvemen
t
project/Quas
i
experimental

Participants
: n= 3,227
Total after
application
of inclusion
criteria:
n
=889
gender,
marital
status,
referral
source,
stroke type

79
hospitals
56% men,
65% white,
77%
admitted w/
ischemic
stroke, 48%
identified
depressed.
Age range
26-97.
Gender,
ethnicity.
Past

logistic
regression
, linear
regression
, STATA
version 12

When depression score
treated as a continuous
variable female sex
only factor
associated with higher
score (p = 0.017)

5.

Level of evidence for PICOT question
type: IV
6. Quality of evidence: moderate
USPSTF: B Level of Certainty: moderate

Screening positive was
not associated w/ poor
discharge/day 7
outcome (mRS > 3; OR
1.45, 95% CI 0.74-2.83)
IV=
participation
in homebased
rehabilitation
program
DV= identify
variables that
correlate with
depressive
symptoms

FIM, RNLI,
PHQ-9,

Logistic
regression
analysis

Regression
demonstrates (OR=
1.89, p = 0.04), low
RNLI scores (OR =
0.92; p = 0.001), and
younger age ( OR =
0.96; p < 0.001)
predicted patients
having moderate to
severe depressive
symptoms.

1.
2.

3.
4.
5.
6.
7.

IV= patients
with acute
stroke
DV=
depression
screening

PHQ-9,
Descriptiv
e statistics
Pearson
correlatio
n tes,
chisquare,
SD

Of 79 patients screened
48% (n=39) found to be
depressed. History of
depression (x2= 17.09,
p=.002) more likely to
have higher levels of
depression.

8.

Strength: study demonstrates the need
for continuous screening of pt for
depressive symptoms
Limitations: the study used
retrospective data from a large
administrative database. Tool does not
formally dx pt with depression
Risk of harm: none
Feasibility: good feasibility
Level of evidence for PICOT question
type: IV
Quality of evidence: moderate
USPSTF: C
Level of Certainty: moderate

Strength: identifies the need for
implementation specific to the
deficit.
2. Limitation: retrospective chart
review design and short
implementation phase
3. Risk of harm: none
4. Feasibility: good feasibility
5. Level of evidence for PICOT
question type: Level V
6. Quality of evidence: moderate
7. USPSTF: C
Level of Certainty: moderate
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medical
history.

Article #4

Kapoor et al.
(2019).
Screening
for poststroke
depression
and
cognitive
impairment
at baseline
predicts
long-term
patientcentered
outcomes
after stroke.
Article #5
Babkair, L.
A. (2017).
Risk factors
for
poststroke
depression:
An
integrative
review.

Prospective
longitudinal
cohort study

Participants
: n=1504
Age range
17-100
Total after
inclusion
n= 124;
study
cohort,
eligible
patients,
enrolled.
Attrition
65(24.1%)

None
noted

Integrative
review

PubMed,
Cumulative
Index to
Nursing &
allied
health
literature,
& PsycInfo
Initial #
found: 406
18 met
inclusion
criteria
3 crosssectional
14
prospective
cohort
1 case
control

IV =poststroke
depression
DV =
cognitive
impairment

FAI, RNLI,
PHQ, BDI,
MoCA

Univariate
and
multivaria
te linear,
logistic
regression
analyses

Older age (ß =-1.25,
p=.046), greater stroke
severity (ß = 1.84,
p=.015), more
depressive (ß=-2.41,
p=.023), cognitive (ß=2.15, p= .046) measure
of executive function
were strongest
correlates to poor
activity

9.

Strength: results highlight the
the importance post-stroke
depression
and cognitive screening
2. Limitation: attrition and survivor
bias
3. Risk of harm: none
4. Feasibility: fair feasibility
5. Level of evidence for PICOT
question
type: Level IV
6. Quality of evidence: moderate
7. USPSTF: B
Level of Certainty: moderate

IV=
poststroke
depression
DV= risk
factors

HADS, DSM-IV

Univariate
&
multivaria
te linear
regression
, t Test,
MannWhitney,
thematic
analysis

Significant markers for
PSD at 3 and 12 months
(OR, 2.66;95% CI,
1.35-5.27; p=.005).
Patient non acceptance
of disability at 1 month
predicted depression at
9 months (OR,
1.19;95% CI, 1.05-1.35)

10. Strength: the use if multivariate
statistical analysis
2. Limitation: western studies and
lack of cultural variation, race, &
ethnicity as risk factors.
3. Risk of harm: none
4. Feasibility: good feasibility
5. Level of evidence for PICOT
question
type: Level V
6. Quality of evidence: moderate
7. USPSTF: C
Level of Certainty: moderate
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M age of
sample
56.3 -80
11. Strength: identified the use of
Comprehensive assessment help
Recognize high risk patients
2. Limitation: small sample size and
non-RCT design
3. Risk of harm: none
4. Feasibility: good feasibility
5. Level of evidence for PICOT
question
type: VII
6. Quality of evidence: low
7. USPSTF: C
Level of Certainty: low

Article #6
Zhao, F. -Y
et al. (2018).
Clinical
practice
guidelines
for poststroke
depression
in China

None
stated

Systematic
review

Metaanalysis of
8 week
trials of
antidepress
ant.

IV= post
stroke
depression
DV= clinical
practice
guidelines

BDI, PHQ-9,
HADS

Percentag
es

No specific
characteristics were
found

Article #7
Ezema et
al. (2018).
Influence
of poststroke
depression
on
functional
independen
ce in
Activities
of daily
living.
Article #8
Amaricai,
E. &
Poenaru,
D. V.
(2016).
The poststroke
depression
and its

None

Cross
sectional
study/descri
ptive

N=66
42=female
24 males

IV= poststroke
depression
DV=
functional
recovery

HAM-D, BI

Cronbach’
s alpha
Pearson’s
r
Chisquared,
upaired ttest
Descriptiv
e
statistics,
mean,
standard
deviation

Post-stroke depression
was associated with
poor level functional
independence (P=0.000)

1. Strength: none specified
2. Limitation: no standardized stroke
duration. Inability to conduct
retrospective assessment.
3. Risk of harm: no
4. Feasibility: good feasibility
5. Level of evidence for PICOT
question type: VI
6. Quality of evidence: low
7. USPSTF: C
Level of Certainty: low

None
named

Cross
sectional
descriptive

N=89
54=men
18= women
72 met
inclusion
criteria.
Age range
29-59

IV= impact
on
functioning of
young and
adult stroke
patients
DV=
frequency,
degree of
PSD

BDI, Hamilton
scale, SIS

Mean,
standard
deviation,
pearson’s
correlatio
n
Appendix
24nt,
unpaired
t-test

Using BDI 5 patients
(7%) had normal ups &
downs
19 patients (26.3%) had
mild mood disturbances
Remaining 48 patients
(66.6%) with borderline
clinical depression.

1. Strength: none noted
2. Limitation: Small sample size,
limited to single rehabilitation unit.
3. Risk of harm: no
4. Feasibility: good feasibility
5. Level of evidence for PICOT
question type: VI
6. Quality of evidence: moderate
7. USPSTF: B
Level of Certainty: moderate
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•

impact on
functioning
in young
and adult
stroke
patients of
a
rehabilitati
on unit.

D
V
=

GraphPad
prism

F
r
e
q
u
e
n
c
y
T
h
e
d
e
g
r
e
e
o
f
P
S
D

Article #9
Torrisi et
al. (2018)
SelfEfficacy,
poststroke
depression,
and

None

Descriptive
study

N=38
21= female
17= men

IV= selfefficacy
DV= poststroke
depression

MADRS, FIM,
GSE

Multivaria
te
regression
, t=test,
Std Err, ß,
regression
coefficient

FIM (t=6.87 ;
P <, .0001)
MADRS (t= 4.27 ; P
< .001)
SE (t= 5.01 ; P < .001)
No significant
difference was found
between men and

1. Strength: none documented
2. Limitation: small sample size, no
evaluation of the correlation od
depressive mood with the brain lesion
side & size
3. Risk of harm: no
4. Feasibility: feasibility
5. Level of evidence for PICOT
question

STROKE DEPRESSION SCREENING
rehabilitati
on
outcomes:
Is there a
correlation?
Article #10
Harris et al.
(2017).
Depression
and
functional
status
among
African
American
stroke
survivors in
inpatient
rehabilitati
on.

26
women for FIM &
MADRS

type: VI
6. Quality of evidence: low
7. USPSTF: C
Level of Certainty: low

None
named

Cohort
Study

n= 458
age sample
range 1898
> than half
were males

IV= African
American
DV=
functional
status

FIM total
FIM motor
FIM cognitive

Chisquare,
t-tests,
Fisher’s
Exact test,
multiple
regression
models

African Americans with
PSD were more
functionally impaired at
discharge from
rehabilitation than those
without depression.

1. Strength: none documented
2. Limitation: under-reported
depression
3. Risk of harm: none
4. Feasibility: good feasibility
5. Level of evidence for PICOT
question type: IV
6. Quality of evidence: low
7. USPSTF: C
Level of Certainty: low

Article #11
Ezekiel et al.
(2018).
Factors
associated
with
participation
in life
situations for
adults with
stroke: A
systemic
review

none

RS & metaanalysis

n= 33
18-99 years
old

IV = Adults
of stroke
DV=
participation
in life
situations

CI, ICF

binomial
test,
univariate,
regression
analysis,
correlatio
n

Older people with more
severe stroke and stroke
related impairments are
most at risk for poor
participation

1. Strength: the broad scope of the
review
2. Limitation: limitation in ADLs
was strongly associated with poor
participation with studies reporting
medium to large size effect
3. Risk of harm: none
4. Feasibility: excellent feasibility
5. Level of evidence for PICOT
question type: I
6. Quality of evidence: moderate
7. USPSTF: B
Level of Certainty: moderate

Article #12
Sharma et
al. (2021).
Post-stroke
depression
ans its
effects on
functional

None

IV= poststroke
DV=
functional
outcomes

HADS-D,
HDRS, BI, SSS,
MRS,

Descriptiv
e
statistics,
chisquare,
Wilcoxon
rank sum
test, Mann

Negative correlation
between HADS &
HDRS. Functional
outcomes in stroke
survivors with &
without PSD improve
with comprehensive
inpatient rehab.

1. Strength: non documented
2. Limitation: small sample size,
assessment of depression by self-report
questionnaires
3. Risk of harm: none
4. Feasibility: good feasibility
5. Level of evidence for PICOT
question type: IV

Medline,
CINAHL,
AMED,
Psych
INFO, Web
of Science

Casecontrol study

n= 30
18 males
12 females

STROKE DEPRESSION SCREENING
outcomes
during
inpatient
rehabilitatio
n.

27
Whitney,
Spearman
test

6. Quality of evidence: moderate
7. USPSTF: C
Level of Certainty: moderate

Legend:
ADL= Activities of Daily Living, B-ADL = Barthel Activity Living Index, BDI= Beck Depression Inventory, DSM-IV= Diagnostic and statistical Manual of Mental Disorders, DV=
dependent variable, EQ-5D = EuroQol Five Dimensions Questionnaire, FAI= Frenchay Activities Index, FIM = Functional Independence Measure, FOIS = Functional Oral Intake
Scale, GSE= General Self-efficacy scale, HADS-A= hospital and anxiety depression scale-anxiety, HADS-D= hospital and anxiety depression scale-depression, Hamilton depression
rating scale (HAM-D), ICF= International classification of functioning, ICH- intracranial hemorrhage, IS= ischemic stroke, IV= Independent variable, LB-IADL = Lawton-Brody
Instrumental Activity Daily Living Scale, MC= medical center, MNA = Mini Nutritional Assessment, MoCA= Montreal Cognitive Assessment, MADRS=Montgomery-Asberg
Depression Scale, mRS= modified Rankin Scale, NIHSS= National Institutes of Health Stroke Scale, OR = odds ratio, PAC program= post-acute care program, PANAS= positive and
negative affective scale, PHQ-9= Patient Health Questionnaire, PosMT= positive mental training tool, PSD= port stroke depression, RNLI = reintegration to normal living index,
SD= standard deviation, SIS= Stroke Impact Scale
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Appendix B
PHQ-9 Screening Tool
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Appendix C
Flowchart
The goal is for a Spring 2022 opening of 12 to 14 beds, two of which will be
intensive care beds. These beds will be the small-scale implementation.

Implementation of depression screening tool into the EHR on unit opening
day

During the orientation process for the nurses hired for the unit, the
education for the depression screening tool will be introduced. Each nurse
will be required to complete the education within 1 week of hire

By week two of re-opening every patient admitted to the stroke unit
should be assessed for depression screening

Week 3, individual reports will be analyzed for missed screening tools, reeducation will occur

At the 1-month mark comparison of discharged patient who received
rehabilitation and depression treatment will assessed. An accurate count of
patients will be needed to understand future requirements

Re-evaluation of stroke patients needs and for possible adjust to the plan
will be ongoing.

Acutal Date Pending
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Appendix D
Evaluation of Depression screening tool Survey Pre & Post evaluation for Stroke Unit

Depression screening tool Project
Pre-evaluation
Shift
AM
1. Are you familiar with the stroke
depression screening tool?
2. Do you know how to perform
the depression screening tool?

YES

NO

PM
AM
YES

NO

YES

NO

YES

NO

YES

NO

PM
3. Do you understand the purpose
of the depression screening tool?

AM
PM

4. Is it useful to your practice?

AM
PM

5. Do you use the screening tool for AM
each newly admitted patient?
PM
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Evaluation of Depression screening tool Survey Pre & Post evaluation for Stroke Unit

Depression screening tool Project
Post-evaluation
Shift
AM
1. Are you familiar with the stroke
depression screening tool?
2. Do you know how to perform
the depression screening tool?

YES

NO

PM
AM
YES

NO

YES

NO

YES

NO

YES

NO

PM
3. Do you understand the purpose
of the depression screening tool?

AM
PM

4. Is it useful to your practice?

AM
PM

5. Do you use the screening tool for AM
each newly admitted patient?
PM

What way can the depression screening protocol be improved? __________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________

